Long-term outcome analysis of Y90 radioembolization in hepatocellular carcinoma

BACKGROUND: Yttrium-90 (Y90) radioembolization is a catheter-based therapy for hepatocellular carcinoma (HCC). Multiple trials have evaluated the efficacy of Y90 in HCC; however, few have assessed long-term hepatic function. This study aimed to evaluate a clinical real-world experience of Y90 effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Hannah M., Alder, Laura, Nguyen, Matthew, Dougherty, Sean C., Qu, Yuesheng, Thacker, Leroy R., Poklepovic, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331743/
https://www.ncbi.nlm.nih.gov/pubmed/37435218
http://dx.doi.org/10.21037/jgo-22-882

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331743/
https://www.ncbi.nlm.nih.gov/pubmed/37435218
http://dx.doi.org/10.21037/jgo-22-882

Ejemplares similares